Press release
Saliva-based Screening Market is Poised to Grow at a CAGR of 8.0% to Reach US$ 810.9 Million by 2034
Saliva-based Screening Market
The increasing demand for saliva-based screening is driven by its advantages as a non-invasive and less intrusive alternative to blood-based diagnostics. This method is especially valuable in point-of-care environments and remote or underserved regions with limited healthcare access. Additionally, saliva collection is simpler and quicker than traditional blood draws, enabling more frequent health monitoring while easing the strain on healthcare systems.
For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=9740
What are Some Lucrative Opportunities in the Saliva-based Screening Market?
"Ongoing Research Expands Saliva-based Screening's Diagnostic Potential from Personalized Medicine to Clinical Trials"
Current research is uncovering new biomarkers within saliva, broadening the spectrum of diseases and conditions that saliva-based screening can detect. Technological advancements are enabling more detailed biomarker profiling, paving the way for personalized medicine approaches. This means treatments could be customized based on an individual's unique saliva profile, enhancing therapeutic effectiveness.
Such innovations hold significant promise, particularly in resource-constrained environments or during public health crises, where rapid and accurate diagnostics are critical. Additionally, saliva-based screening is increasingly being integrated into clinical trials, offering a non-invasive tool for monitoring patient responses and disease progression, further expanding its market potential.
Country-wise Insights
The saliva-based screening market has a strong presence in North America and East Asia. North America is projected to hold a significant 33.5% share of the global market in 2024, with an anticipated CAGR of 7.6% throughout the forecast period.
East Asia also commands a notable portion of the market, accounting for an estimated 19.1% share in 2024. The region is expected to experience robust growth, with a projected CAGR of 9.3% during the same period, reflecting increasing adoption and demand for saliva-based screening technologies.
Category-wise Insights
Saliva-based screening is rapidly gaining traction among patients, manufacturers, and producers who value its non-invasive nature. The simplicity of sample collection, combined with its versatility in diagnosing a wide range of health conditions, makes saliva-based screening an attractive and dependable diagnostic option.
This growing acceptance enables manufacturers and producers to scale up production, making these tests more affordable and widely accessible for patients. As awareness spreads among healthcare providers, patients, and industry stakeholders about the advantages of saliva-based diagnostics, demand for these tests is expected to rise steadily.
Competitive Landscape
Prominent players in the saliva-based screening market include Thermo Fisher Scientific, Inc., Neogen Corporation, Abbott, Sarstedt AG & Co. KG, Autogen, Inc., Oasis Diagnostics, Porex, Salimetrics, LLC, Takara Bio, Inc., Arcis Bio, and Orasure Technologies.
Innovative companies such as Molbio Diagnostics, Testi Technologies, and emerging firms like Salilistic are playing pivotal roles in driving technological breakthroughs. These innovations encompass rapid point-of-care saliva testing devices, expanding diagnostic uses beyond infectious diseases, and integrating advanced genomic and proteomic analyses. Market leaders are heavily investing in research and development to improve diagnostic accuracy, identify new biomarkers, and broaden the range of saliva-based screening applications.
Recent Developments:
On December 15, 2023, Molbio Diagnostics, based in Goa, partnered with Finland's Testi Technologies to commercialize PROMILLESS, a saliva-based self-test kit for measuring blood alcohol content. This collaboration aims to improve accessibility and advance diagnostic technology.
On August 28, 2023, researchers investigated automated saliva-based PCR testing for COVID-19 surveillance, publishing findings on the medRxiv preprint server detailing its implementation in an educational setting.
On June 21, 2023, Salilistic launched the world's first saliva-based pregnancy test in the UK, marking a significant leap in home pregnancy detection by eliminating the need for urine samples.
Browse Full Report: https://www.factmr.com/report/saliva-based-screening-market
Segmentation of the Saliva-based Screening Market
By Product Type :
Saliva Collection Kits
Saliva Nucleic Acid Purification Kits,
Saliva Based Detection Kits
By Purpose :
Research Use Only
Diagnostics
By Application :
Infection Analysis/Detection (Non- COVID)
Genomic Analysis
Proteomics
Pharmacogenomics
Liquid biopsy
By End User :
Hospitals & Clinics
Diagnostic Laboratories
Academic and Research Institutes
Biopharmaceuticals and CROs
By Region :
North America
Latin America
Europe
East Asia
South Asia & Oceania
Middle East & Africa
Check out More Related Studies Published by Fact.MR:
Esophageal Stents Market
https://www.factmr.com/report/esophageal-stents-market
Artificial Kidney Market
https://www.factmr.com/report/artificial-kidney-market
OTC Pediatric Healthcare Market
https://www.factmr.com/report/257/otc-pediatric-healthcare-market
Microdontia Treatment Market
https://www.factmr.com/report/microdontia-treatment-market
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com
About Fact.MR
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Saliva-based Screening Market is Poised to Grow at a CAGR of 8.0% to Reach US$ 810.9 Million by 2034 here
News-ID: 4054409 • Views: …
More Releases from Fact.MR
Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
The latest report on the Bioinformatics Market, projecting robust growth driven by the increasing demand for genomic research, advancements in artificial intelligence (AI), and the rising adoption of precision medicine. Valued at USD 14.29 billion in 2024, the global market is forecast to expand at a compound annual growth rate (CAGR) of 13.4%, reaching USD 50.25 billion by 2034. This significant growth underscores the critical role of bioinformatics in decoding…
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Ke …
Fact.MR today released its latest report on the Residential Robotic Vacuum Cleaner Market, projecting robust growth driven by increasing demand for automation, busy lifestyles, and advancements in smart home technologies. Valued at USD 3.0 billion in 2023, the global market is forecast to expand at a compound annual growth rate (CAGR) of 14.4%, reaching USD 11.6 billion by 2033. This significant growth highlights the rising adoption of robotic vacuum cleaners…
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
The global brain-computer interface (BCI) market was valued at USD 1.6 billion in 2022 and is projected to reach USD 6.5 billion by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2023 to 2033. This expansion reflects the increasing adoption of BCI technologies in medical applications, driven by advancements in neuroscience, AI, and sensor technologies. BCIs enable direct communication between the brain and external devices, offering…
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2 …
The global orally disintegrating tablet (ODT) market is valued at USD 24.45 billion in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 11.5%, reaching USD 72.68 billion by 2034. This robust growth is driven by the increasing demand for patient-friendly dosage forms, particularly among the elderly, pediatric, and dysphagic populations, who benefit from ODTs' ease of administration without water and rapid dissolution. ODTs enhance…
More Releases for Saliva
Primary Catalyst Driving Artificial Saliva Market Evolution in 2025: Impact of R …
What market dynamics are playing a key role in accelerating the growth of the artificial saliva market?
The increasing incidence of dry mouth syndrome, also known as xerostomia, is projected to fuel the growth of the artificial saliva market. Xerostomia is marked by a continuous sense of dryness in the mouth. The upsurge in this condition has been largely due to the aging demographic, as well as the prevalent use of…
Artificial Saliva Market : An Overview
Introduction:
Artificial saliva is a synthetic product designed to mimic the natural saliva found in the human mouth. It is primarily used to alleviate symptoms associated with xerostomia, or dry mouth, a condition caused by reduced or absent saliva production. Xerostomia is often linked to medical conditions such as Sjögren's syndrome, radiation therapy for head and neck cancer, or side effects from certain medications. Artificial saliva products help to maintain oral…
Artificial Saliva Market
Artificial saliva is a synthetic product designed to replicate the functions of natural saliva in individuals who suffer from conditions that reduce saliva production. Dry mouth, also known as xerostomia, can result from various factors including aging, medication side effects, radiation therapy for cancer, or diseases like Sjögren's syndrome. Natural saliva plays a crucial role in maintaining oral health, aiding in digestion, and protecting the mouth from infections. When the…
Saliva Test Devices Market Scope and Market Size
The measurement of hormones such as cortisol, estrogens, progesterone, and androgens is done using saliva testing, a non-invasive collection technique in which patients collect their saliva in plastic tubes. Because they can gather their sample in the privacy of their home or workplace, this non-invasive saliva collection is perfect for patients.
Full Access Of Report:
https://www.databridgemarketresearch.com/reports/global-saliva-test-devices-market
Top Trending Reports:
https://marketingofreport.wordpress.com/2024/02/02/717/
https://1234submission1234.blogspot.com/2024/02/saliva-test-devices-market-scope-and.html
https://marketingofreport.wordpress.com/2024/02/02/721/
The saliva test devices market is segmented on the basis of type and application. The…
Wearable devices to dominate the Artificial Saliva Market
The Artificial Saliva Market is likely to grow on a robust note in the next decade. The next decade would be seeing the integration of telehealth services with the physical ones that exist at the moment. Urgent care and primary care are bound to be accessed through virtual visits, along with improvement in collaboration with the clinics, dialysis centres, long-term care facilities, and mental health services. This shifting is to…
New HGH Saliva Antigen Covid Test gamechanger
An Austrian company HGH Disinfection und Cosmetique Gmbh, based in 9020 Klagenfurt created with a Korean partner a unique antigen salvia test unit which is so simple that anybody can use it. Till now mass testing was nasal stick by government and doctors. Now this new test unit can be used by everybody without a scarry stick in the nose and a result with 95% is ready in 10…
